Skip to content

Helen Of Troy HELE Increase Decrease In Receivables

Increase Decrease In Receivables at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$13.1M-1,256%
ICF International logo
ICF InternationalICFI
$2.85M+113%
V2X logo
V2XVVX
$90.7M+1,495%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$474K-96.6%
Lithium Americas logo
Lithium AmericasLAC
$585K+760%
Schneider National logo
Schneider NationalSNDR
$59.9M+558%

Other financials

Income statement

See full
Revenue$470.0M-3.3%
Gross profit$209.7M-11.1%
Operating income-$51.0M-2,629%
Net income-$55.6M-209%
EPS (diluted)-$2.38-207%

Balance sheet

See full
Cash & equivalents$18.9M+0.1%
Total debt$840.7M-12.7%
Total equity$798.2M-52.6%
Total assets$2.1B-32.5%

Cash flow

See full
Operating cash flow$111.3M+218%
CapEx$8.2M+3.8%
Free cash flow$103.1M+281%

Valuation

See full
Market cap$648.22M+5.7%
Enterprise value$1.47B-2.2%
P/S0.4×0.0×

Profitability

See full
Gross margin45.7%-2.3pp
Operating margin-43.8%-51.3pp
Net margin-50.3%-56.8pp
FCF margin6%-3.1pp

Returns & leverage

See full
Return on equity-72.5%-79.9pp
Debt / equity1.1×+0.5×
Current ratio1.7×-0.3×

Where this comes from

Reported directly by Helen Of Troy in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.

The official record: Helen Of Troy’s 10-Q, filed January 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Helen Of Troy's increase decrease in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Helen Of Troy's increase decrease in receivables?
Helen Of Troy (HELE) reported increase decrease in receivables of $83.59M in Q3 2025.
How has Helen Of Troy's increase decrease in receivables changed year-over-year?
Helen Of Troy's increase decrease in receivables decreased by 5.2% year-over-year, from $88.15M to $83.59M.